Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
NHS Wales Shared Services Partnership
2nd Floor Woodland House, Maes-y-Coed Road
Cardiff
CF14 4TT
UK
Telephone: +44 2921508271
E-mail: Owen.rees3@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://www.procurement.wales.nhs.uk
Address of the buyer profile: http://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Regional or local authority
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme
Reference number: CAV-ITT-PROJECT53738
II.1.2) Main CPV code
79419000
II.1.3) Type of contract
Services
II.1.4) Short description
NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme.
The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales.
We require a robust and independent assessment of the impact of the SCP programme.
The following key programme deliverables were identified:
· To review, develop and publish the National Optimal Pathways.
· In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach.
· Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment).
· Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients.
· Work collaboratively with health boards and stakeholders to share learning from the programme activities.
Programme aim and objectives
Aim:
· To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data.
Objectives:
· To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways.
· To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways.
To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
99 920.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
79419000
II.2.3) Place of performance
NUTS code:
UKL22
Main site or place of performance:
NHS Collaborative - Cardiff
II.2.4) Description of the procurement
NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme.
The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales.
We require a robust and independent assessment of the impact of the SCP programme.
The following key programme deliverables were identified:
· To review, develop and publish the National Optimal Pathways.
· In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach.
· Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment).
· Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients.
· Work collaboratively with health boards and stakeholders to share learning from the programme activities.
Programme aim and objectives
Aim:
· To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data.
Objectives:
· To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways.
· To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways.
To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 70%
Price
/ Weighting:
30%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2023/S 000-016823
Section V: Award of contract
Contract No: CAV-ITT-PROJECT53738
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
18/12/2023
V.2.2) Information about tenders
Number of tenders received: 14
Number of tenders received from SMEs: 6
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 14
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Carnall Farrar
91 Wimpole Street
London
W1G0EF
UK
Telephone: +44 2037707536
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 99 920.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
Please note additional information on this procurement:
1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award
contract.
2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the ITT and that save for matters
of clarification or consistency the Contracting Authority will not negotiate the terms.
3. The Contracting Authority will not accept completed ITT's after the stated closing date.
4. All documents to be priced (where applicable) in sterling and all payments made in sterling.
5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders.
6. In reference to II.1.9 (Variants) to the extent permitted, if at all, in the tender documents.
7. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale
ULHB.
NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at
http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=65818.
NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on
Sell2Wales at http://www.sell2wales.gov.wales/search/search_switch.aspx?ID=68368
(WA Ref:68368)
The Health Board will ensure that this procurement process, which is being undertaken in accordance with the Open Procedure, pursuant to and as defined in the Public Contracts Regulations 2015 (as amended) Light Touch Regime.
(WA Ref:142164)
VI.4) Procedures for review
VI.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Internet address(es)
URL: http://www.procurement.wales.nhs.uk
VI.5) Date of dispatch of this notice
13/06/2024